Regulatory Landscape Newsletter – February 2024

This is our Regulatory Landscape newsletter for February 2024 with our monthly insights on the evolving market for Regulatory professionals.   

For the month of January there were approximately 80 new Regulatory positions posted at smaller biotech and pharma companies in the US. This is up 76% from December but down 22% from January 2023. 

49% of these new positions in January were in Clinical Regulatory Strategy and 27% were in CMC Regulatory, 13% were in Advertising, Promotions & Labeling, and 11% in Regulatory Operations.  More than 50% of these roles were at Director level and above. There were only five new Regulatory VP/SVP positions posted in January.  

51% of all new Regulatory roles in January were posted as Remote and 16% were Hybrid (remote/onsite).   30% of the January Regulatory positions were in California, 43% were in Massachusetts, and 10% in New Jersey. 

There were layoffs announced at 21 biotech and pharma companies in January. This is up from 12 companies in December and 15 in January 2023.    Biotech initial public offerings appear to be on the rise.  There have been seven IPOs so far this year, versus 19 for the entirety of 2023. 

We recently helped our client to fill a Regulatory CMC Vice President position and you can see a Case Study about this search (along with some others) here on our site: .  

In January we published our 2023 Regulatory Year-End Recap which you can view here: 

Please consider us for your Regulatory hiring or let us know if you are considering a career change soon.